Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
David Mcintyre currently holds 986,319 shares of Avita Therapeutics, Inc. (RCEL), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, David Mcintyre has been a net seller of RCEL stock. They have purchased $16.1K and sold $6.1M worth of shares.
David Mcintyre's most recent insider trade was on Jan 5, 2026, when they sold 986,319 shares at $0.00 per share.
David Mcintyre serves as Executive at Avita Therapeutics, Inc. (RCEL). They have executed 65 insider transactions totaling $6.1M over their tenure at the company.
David Mcintyre holds the position of Executive at Avita Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 17 years and currently hold a stake valued at $0.
David Mcintyre has shown a selling trading pattern, with $16.1K in total purchases and $6.1M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by David Mcintyre was on Sep 19, 2011, when they sold $817.0K worth of HTWR shares. This transaction involved 14,917 shares at $54.77 per share.
David Mcintyre currently owns 986,319 shares of Avita Therapeutics, Inc. (RCEL), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of David Mcintyre's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. David Mcintyre has 65 Form 4 filings on record as an insider at Avita Therapeutics, Inc..
Set alerts for David Mcintyre and 40,000+ other insiders.